ArticleJournal of neuroendocrinology2026
Milk and infant plasma hormone concentrations predict sweet and fat taste acceptance and later food intake.
Article in Journal of neuroendocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05798676 (Maternal Characteristics Associated With Child Growth and Adiposity. Search for Nutrigenomic Biomarkers in Peripheral Blood), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Maternal Characteristics Associated With Child Growth and Adiposity. Search for Nutrigenomic Biomarkers in Peripheral Blood
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Early-life exposure to metabolic hormones may influence the development of taste acceptance and subsequent intake of hyperpalatable foods (HPF) in infants, but evidence integrating hormonal, behavioral, and dietary data in humans is limited. Therefore, our objective was to determine whether concentrations of insulin, leptin, cortisol, and liver-expressed antimicrobial peptide 2 (LEAP2) in human milk and infant plasma at 6 months predict infant sweet and fat taste acceptance and HPF intake later in infancy. In this prospective cohort study, human milk and infant plasma were collected at 6 months and analysed for insulin, leptin, cortisol, and LEAP2. At 18 months, sweet and fat taste acceptance were assessed using ingestion ratio (IR; motivational drive) and liking ratio (LR; hedonic response). HPF intake was quantified from standardized 24-h dietary recalls. Associations were evaluated using multivariable linear regression. Eighty two mother-infant pairs were enrolled, of which 28 completed follow-up and were included in the final analysis. Milk LEAP2 was positively associated with fat IR (p = .037). Milk insulin was inversely associated with sweet IR (p = .003) and LR (p = .020), while milk leptin was positively associated with sweet IR (p = .013) and LR (p = .018) and inversely associated with HPF intake consumption (p = .001). Milk cortisol was positively associated with fat (p = .043) and sweet IR (p = .014). In contrast, infant plasma LEAP2 was inversely associated with fat IR (p = .018) and HPF intake (p = .002) but positively associated with sweet IR (p = .005) and LR (p = .023). Infant plasma cortisol was directly associated with HPF intake (p = .006) and inversely associated with sweet and IR (p = .004) and fat LR (p = .009). Milk-derived and endogenous metabolic hormones were differentially associated with taste acceptance and HPF intake, identifying specific hormonal pathways that may shape early feeding behavior and later food intake. Clinical Trial Registry: This study was registered at clinicaltrials.gov as NCT05798676. https://clinicaltrials.gov/study/NCT05798676.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.